Although accumulating evidence suggests that the inhibition of IL-6 can exert a protective effect on the brain, studies by Ali et al. showed that ischemia-induced IL-6 was an endogenous cytokine that exerted neuroprotective effects against NMDA receptor-mediated injury [50, 51]. The gene discussed is IL6; the disease is ischemia.